John T. Schiller

38.1k total citations · 7 hit papers
292 papers, 27.8k citations indexed

About

John T. Schiller is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, John T. Schiller has authored 292 papers receiving a total of 27.8k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Epidemiology, 106 papers in Immunology and 71 papers in Genetics. Recurrent topics in John T. Schiller's work include Cervical Cancer and HPV Research (194 papers), Hepatitis B Virus Studies (89 papers) and Immunotherapy and Immune Responses (75 papers). John T. Schiller is often cited by papers focused on Cervical Cancer and HPV Research (194 papers), Hepatitis B Virus Studies (89 papers) and Immunotherapy and Immune Responses (75 papers). John T. Schiller collaborates with scholars based in United States, France and Sweden. John T. Schiller's co-authors include Douglas R. Lowy, Patricia M. Day, Reinhard Kirnbauer, Richard B.S. Roden, N L Hubbert, Christopher B. Buck, Cynthia D. Thompson, Allan Hildesheim, Joakim Dillner and Rhonda C. Kines and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John T. Schiller

287 papers receiving 27.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

1992 883 citations Reinhard Kirnbauer, Douglas R. Lowy et al. Proceedings of the National Academy of Sciences profile →
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

1989 772 citations Douglas R. Lowy, John T. Schiller et al. profile →
Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck

2001 717 citations Egil Jellum, Pentti Koskela et al. profile →
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

2012 542 citations John T. Schiller et al. profile →
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles

1993 504 citations Reinhard Kirnbauer, Douglas R. Lowy et al. Journal of Virology profile →
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

2013 350 citations Rolando Herrero, Wim Quint et al. profile →
Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases

2017 301 citations John T. Schiller et al. profile →

Peers

Countries citing papers authored by John T. Schiller

Since Specialization

Citations

This map shows the geographic impact of John T. Schiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Schiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Schiller more than expected).

Fields of papers citing papers by John T. Schiller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Schiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Schiller. The network helps show where John T. Schiller may publish in the future.

Co-authorship network of co-authors of John T. Schiller

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Schiller. A scholar is included among the top collaborators of John T. Schiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Schiller. John T. Schiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In the activation of HPV-specific human B cells HPV-VLP vaccines mimic membrane-associated antigens 2025 ·Proceedings of the National Academy of Sciences ·(unknown), Haewon Sohn, Brian Dizon, (unknown), Rachel George, Kihyuck Kwak, Munir Akkaya, (unknown), (unknown), Joseph Brzostowski, Denise A. Galloway, Cynthia D. Thompson, Nicolas Çuburu, John T. Schiller, Susan K. Pierce	2
2	Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection 2024 ·Nature Communications ·Gathoni Kamuyu, Filomeno Coelho da Silva, Vanessa Tenet, John Schussler, Anna Godi, Rolando Herrero, Carolina Porras, Lisa Mirabello, John T. Schiller, Mónica S. Sierra, (unknown), Gary M. Clifford, Simon Beddows	2
3	A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates 2023 ·npj Vaccines ·(unknown), Koen K. A. Van Rompay, Maureen Sampson, (unknown), Jennifer Watanabe, (unknown), (unknown), Debbie M. Lovato, John T. Schiller, Alan T. Remaley, Bryce Chackerian	19
4	Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions 2022 ·Journal of Virology ·Nathan R. Fons, Rhonda C. Kines, Cynthia D. Thompson, Patricia M. Day, Douglas R. Lowy, John T. Schiller	10
5	Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial 2022 ·JNCI Journal of the National Cancer Institute ·Shangying Hu, Aimée R. Kreimer, Carolina Porras, Diego Guillén, Mario Alfaro, Teresa M. Darragh, Mark H. Stoler, (unknown), (unknown), Ana Cecilia Rodríguez, Mark Schiffman, Sabrina H. Tsang, Douglas R. Lowy, John T. Schiller, John Schussler, Wim Quint, Mitchell H. Gail, Joshua N. Sampson, Allan Hildesheim, Rolando Herrero, (unknown)	3
6	Harnessing Human Papillomavirus’ Natural Tropism to Target Tumors 2022 ·Viruses ·Rhonda C. Kines, John T. Schiller	8
7	Virus-Like Particle–Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens 2021 ·Cancer Immunology Research ·Rhonda C. Kines, Cynthia D. Thompson, (unknown), Zhenyu Li, (unknown), (unknown), John T. Schiller	27
8	An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma 2017 ·Molecular Cancer Therapeutics ·Rhonda C. Kines, Isabella Varsavsky, (unknown), Debaditya Bhattacharya, (unknown), (unknown), Shin J. Kang, Hans E. Grossniklaus, Demetrios G. Vavvas, (unknown), John R. MacDougall, (unknown), John T. Schiller	45
9	Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial 2013 ·Cancer Prevention Research ·Mahboobeh Safaeian, Carolina Porras, Yuanji Pan, Aimée R. Kreimer, John T. Schiller, Paula González, Douglas R. Lowy, Sholom Wacholder, Mark Schiffman, Ana Cecilia Rodríguez, Rolando Herrero, Troy J. Kemp, Gloriana Shelton, Wim Quint, Leen‐Jan van Doorn, Allan Hildesheim, Lígia A. Pinto, (unknown)	159
10	Reducing HPV-Associated Cancer Globally 2012 ·Cancer Prevention Research ·Douglas R. Lowy, John T. Schiller	173
11	In Vivo Longitudinal Imaging of Experimental Human Papillomavirus Infection in Mice with a Multicolor Fluorescence Mini-Endoscopy System 2011 ·Cancer Prevention Research ·Makoto Mitsunaga, Nobuyuki Kosaka, Rhonda C. Kines, Jeffrey N. Roberts, Douglas R. Lowy, John T. Schiller, (unknown), Akira Hasegawa, Peter L. Choyke, Hisataka Kobayashi	14
12	Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica 2011 ·Cancer Discovery ·Rolando Herrero, Sholom Wacholder, Ana Cecilia Rodríguez, Diane Solomon, Paula González, Aimée R. Kreimer, Carolina Porras, John Schussler, Silvia Jiménez, Mark E. Sherman, Wim Quint, John T. Schiller, Douglas R. Lowy, Mark Schiffman, Allan Hildesheim	116
13	Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human Papillomavirus 2008 ·Journal of Virology ·Katherine M. Johnson, Rhonda C. Kines, Jeffrey N. Roberts, Douglas R. Lowy, John T. Schiller, Patricia M. Day	185
14	Carrageenan Is a Potent Inhibitor of Papillomavirus Infection 2006 ·PLoS Pathogens ·Christopher B. Buck, Cynthia D. Thompson, Jeffrey N. Roberts, Martin Müller, Douglas R. Lowy, John T. Schiller	372
15	Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles 2002 ·The Journal of Immunology ·Bryce Chackerian, Petra H. Lenz, Douglas R. Lowy, John T. Schiller	148
16	Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells 2001 ·The Journal of Immunology ·Petra H. Lenz, Patricia M. Day, Yuk‐Ying S. Pang, Stephan A. Frye, Peter N. Jensen, Douglas R. Lowy, John T. Schiller	214
17	Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers 1997 ·BMJ ·Tone Bjørge, Joakim Dillner, Tarja Anttila, Anders Engeland, Timo Hakulinen, Egil Jellum, Matti Lehtinen, Tapio Luostarinen, Jorma Paavonen, Eero Pukkala, Martin Sapp, John T. Schiller, Linda Youngman, S. Thoresen	58
18	Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study: Table 1 1996 ·BMJ ·Matti Lehtinen, Joakim Dillner, Paul Knekt, Tapio Luostarinen, Arpo Aromaa, Reinhard Kirnbauer, Pentti Koskela, Jorma Paavonen, R Peto, John T. Schiller, Matti Hakama	125
19	Positive and Negative Regulation of Cell Proliferation by E2F-1: Influence of Protein Level and Human Papillomavirus Oncoproteins 1994 ·Molecular and Cellular Biology ·Rosa Marina Melillo, Kristian Helin, Douglas R. Lowy, John T. Schiller	34
20	The Bovine Papillomavirus E5 Oncogene Can Cooperate with ras: Identification of p21 Amino Acids Critical for Transformation by c-ras ^H but Not v-ras ^H 1991 ·Molecular and Cellular Biology ·Berthe M. Willumsen, William C. Vass, Thierry Velu, Alex G. Papageorge, John T. Schiller, Douglas R. Lowy	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact